Fibrocell to Present at 20th Annual Rodman & Renshaw Global Investment Conference
29 août 2018 08h00 HE
|
Fibrocell Science Inc.
EXTON, Pa., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ: FCSC), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective...
Fibrocell Reports Second Quarter 2018 Financial Results and Recent Highlights
09 août 2018 08h00 HE
|
Fibrocell Science Inc.
EXTON, Pa., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ: FCSC), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective...
Fibrocell to Host Conference Call and Webcast on Thursday, August 9, 2018 to Discuss Second Quarter 2018 Financial Results and Recent Highlights
02 août 2018 08h00 HE
|
Fibrocell Science Inc.
EXTON, Pa., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ: FCSC), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective...
Fibrocell Announces Closing of $4.0 Million Registered Direct Offering
05 juil. 2018 16h05 HE
|
Fibrocell Science Inc.
EXTON, Pa., July 05, 2018 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ:FCSC), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue...
Fibrocell Announces $4.0 Million Registered Direct Offering Priced At-the-Market
02 juil. 2018 09h00 HE
|
Fibrocell Science Inc.
EXTON, Pa., July 02, 2018 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ:FCSC), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue...
Fibrocell Announces Closing of $6.0 Million Registered Direct Offering
31 mai 2018 16h05 HE
|
Fibrocell Science Inc.
EXTON, Pa., May 31, 2018 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ:FCSC), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue...
Fibrocell Announces $6.0 Million Registered Direct Offering Priced At-the-Market
29 mai 2018 09h20 HE
|
Fibrocell Science Inc.
EXTON, Pa., May 29, 2018 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ:FCSC), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue...
Fibrocell Announces One-for-Five Reverse Stock Split
24 mai 2018 08h56 HE
|
Fibrocell Science Inc
EXTON, Pa., May 24, 2018 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ:FCSC), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue...
Fibrocell Reports on Interim Results and Progress of Phase 1/2 Clinical Trial of FCX-007 Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa
21 mai 2018 07h00 HE
|
Fibrocell Science Inc
– FCX-007 well-tolerated up to 52 weeks post-administration – – Continued positive trends noted in wound healing and pharmacology signals, including type VII collagen expression and evidence of...
Fibrocell Announces Oral Presentation at 7th International Investigative Dermatology Meeting
16 mai 2018 16h05 HE
|
Fibrocell Science Inc
EXTON, Pa., May 16, 2018 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ:FCSC), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue...